• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同粒径的用于控释的帕利哌酮-阳离子交换树脂复合物

Paliperidone-Cation Exchange Resin Complexes of Different Particle Sizes for Controlled Release.

作者信息

Jee Jun-Pil, Kim Young Hoon, Lee Jun Hak, Min Kyoung Ah, Jang Dong-Jin, Jin Sung Giu, Cho Kwan Hyung

机构信息

College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.

College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Republic of Korea.

出版信息

Pharmaceutics. 2023 Mar 13;15(3):932. doi: 10.3390/pharmaceutics15030932.

DOI:10.3390/pharmaceutics15030932
PMID:36986792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10055564/
Abstract

This study aimed to develop electrolyte complexes of paliperidone (PPD) with various particle sizes using cation-exchange resins (CERs) to enable controlled release (both immediate and sustained release). CERs of specific particle size ranges were obtained by sieving commercial products. PPD-CER complexes (PCCs) were prepared in an acidic solution of pH 1.2 and demonstrated a high binding efficiency (>99.0%). PCCs were prepared with CERs of various particle sizes (on average, 100, 150, and 400 μm) at the weight ratio of PPD to CER (1:2 and 1:4). Physicochemical characterization studies such as Fourier-transform infrared spectroscopy, differential scanning calorimetry, powder X-ray diffraction, and scanning electron microscopy between PCCs (1:4) and physical mixtures confirmed PCC formation. In the drug release test, PPD alone experienced a complete drug release from PCC of >85% within 60 min and 120 min in pH 1.2 and pH 6.8 buffer solutions, respectively. Alternatively, PCC (1:4) prepared with CER (150 μm) formed spherical particles and showed an almost negligible release of PPD in pH 1.2 buffer (<10%, 2 h) while controlling the release in pH 6.8 buffer (>75%, 24 h). The release rate of PPD from PCCs was reduced with the increase in CER particle size and CER ratio. The PCCs explored in this study could be a promising technology for controlling the release of PPD in a variety of methods.

摘要

本研究旨在使用阳离子交换树脂(CERs)开发不同粒径的帕利哌酮(PPD)电解质复合物,以实现控释(包括速释和缓释)。通过筛分商业产品获得特定粒径范围的CERs。PPD-CER复合物(PCCs)在pH 1.2的酸性溶液中制备,显示出高结合效率(>99.0%)。以不同粒径(平均100、150和400μm)的CERs,按PPD与CER的重量比(1:2和1:4)制备PCCs。通过傅里叶变换红外光谱、差示扫描量热法、粉末X射线衍射和扫描电子显微镜等物理化学表征研究,证实了PCC(1:4)与物理混合物之间形成了PCC。在药物释放试验中,单独的PPD在pH 1.2和pH 6.8缓冲溶液中分别在60分钟和120分钟内从PCC中实现了>85%的完全药物释放。另外,用CER(150μm)制备的PCC(1:4)形成球形颗粒,在pH 1.2缓冲液中PPD的释放几乎可以忽略不计(<10%,2小时),而在pH 6.8缓冲液中控制释放(>75%,24小时)。随着CER粒径和CER比例的增加,PPD从PCCs中的释放速率降低。本研究中探索的PCCs可能是一种通过多种方法控制PPD释放的有前景的技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/5d26a179e1c9/pharmaceutics-15-00932-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/219e05ebf124/pharmaceutics-15-00932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/02624c5b0f56/pharmaceutics-15-00932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/f076308373ae/pharmaceutics-15-00932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/31b3be1faf2f/pharmaceutics-15-00932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/dd5dc46eee8f/pharmaceutics-15-00932-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/0c5a3a5390f3/pharmaceutics-15-00932-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/5f89a90325d1/pharmaceutics-15-00932-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/13cf0174f4db/pharmaceutics-15-00932-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/5d26a179e1c9/pharmaceutics-15-00932-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/219e05ebf124/pharmaceutics-15-00932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/02624c5b0f56/pharmaceutics-15-00932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/f076308373ae/pharmaceutics-15-00932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/31b3be1faf2f/pharmaceutics-15-00932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/dd5dc46eee8f/pharmaceutics-15-00932-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/0c5a3a5390f3/pharmaceutics-15-00932-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/5f89a90325d1/pharmaceutics-15-00932-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/13cf0174f4db/pharmaceutics-15-00932-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de43/10055564/5d26a179e1c9/pharmaceutics-15-00932-g009.jpg

相似文献

1
Paliperidone-Cation Exchange Resin Complexes of Different Particle Sizes for Controlled Release.不同粒径的用于控释的帕利哌酮-阳离子交换树脂复合物
Pharmaceutics. 2023 Mar 13;15(3):932. doi: 10.3390/pharmaceutics15030932.
2
Particle design of three-component system for sustained release using a 4-fluid nozzle spray-drying technique.采用四流体喷嘴喷雾干燥技术制备用于缓释的三元体系颗粒设计。
Chem Pharm Bull (Tokyo). 2006 Nov;54(11):1486-90. doi: 10.1248/cpb.54.1486.
3
Complexation between risperidone and amberlite resin by various methods of preparation and binding study.用不同的制备方法研究利培酮与 Amberlite 树脂的络合作用及结合研究。
Drug Dev Ind Pharm. 2009 Dec;35(12):1409-18. doi: 10.3109/03639040902939247.
4
Effect of ion exchange resins on the drug release from matrix tablets.离子交换树脂对基质片剂药物释放的影响。
Eur J Pharm Biopharm. 1998 Nov;46(3):321-7. doi: 10.1016/s0939-6411(98)00056-3.
5
A pH-independent instantaneous release of flurbiprofen: a study of the preparation of complexes, their characterization and in vitro/in vivo evaluation.氟比洛芬的pH非依赖性瞬时释放:配合物的制备、表征及体外/体内评价研究
Drug Dev Ind Pharm. 2017 Sep;43(9):1460-1471. doi: 10.1080/03639045.2017.1318908. Epub 2017 Apr 24.
6
Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release.普萘洛尔-硅酸镁铝复合物分散体和颗粒:特性及影响药物释放的因素。
Int J Pharm. 2010 Jan 4;383(1-2):106-15. doi: 10.1016/j.ijpharm.2009.09.016. Epub 2009 Sep 12.
7
Application of ion exchange resin in floating drug delivery system.离子交换树脂在漂浮型药物递送系统中的应用。
Drug Dev Ind Pharm. 2008 Oct;34(10):1117-24. doi: 10.1080/03639040801973982.
8
Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix.作为药物递送基质的离子交换树脂复合物的载药和释药特性。
Int J Pharm. 2008 Sep 1;361(1-2):26-32. doi: 10.1016/j.ijpharm.2008.05.006. Epub 2008 May 15.
9
Molecular properties of propranolol hydrochloride prepared as drug-resin complexes.制备成药物-树脂复合物的盐酸普萘洛尔的分子性质
Drug Dev Ind Pharm. 2001 Apr;27(4):359-64. doi: 10.1081/ddc-100103736.
10
Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.抗组胺药物的单宁酸盐配合物:缓释和掩味方法。
Int J Pharm. 2012 Jan 17;422(1-2):91-100. doi: 10.1016/j.ijpharm.2011.10.033. Epub 2011 Oct 21.

引用本文的文献

1
Design, Development, Evaluation, and In Vivo Performance of Buccal Films Embedded with Paliperidone-Loaded Nanostructured Lipid Carriers.载帕利哌酮纳米结构脂质载体口腔膜的设计、开发、评价及体内性能
Pharmaceutics. 2023 Oct 25;15(11):2530. doi: 10.3390/pharmaceutics15112530.

本文引用的文献

1
Hydroxypropyl-β-cyclodextrin-based solid dispersed granules: A prospective alternative to conventional solid dispersion.基于羟丙基-β-环糊精的固体分散颗粒:传统固体分散体的前瞻性替代选择。
Int J Pharm. 2022 Nov 25;628:122286. doi: 10.1016/j.ijpharm.2022.122286. Epub 2022 Oct 14.
2
Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution.用于提高溶解度和溶出度的载盐酸帕唑帕尼四组分自纳米乳化药物递送系统预浓缩物的制备与表征
Pharmaceutics. 2022 Sep 5;14(9):1875. doi: 10.3390/pharmaceutics14091875.
3
Production and Application of Biomaterials Based on Polyvinyl alcohol (PVA) as Wound Dressing.
基于聚乙烯醇(PVA)的生物材料的生产与应用:创伤敷料。
Chem Asian J. 2022 Nov 2;17(21):e202200595. doi: 10.1002/asia.202200595. Epub 2022 Sep 19.
4
Development of Alectinib-Suspended SNEDDS for Enhanced Solubility and Dissolution.用于提高溶解度和溶出度的阿来替尼混悬型自乳化药物传递系统的研发
Pharmaceutics. 2022 Aug 14;14(8):1694. doi: 10.3390/pharmaceutics14081694.
5
Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects.解析载帕利哌酮的脂质纳米构建体增强脑内递药:药代动力学、行为学、生物化学和组织学方面。
Drug Deliv. 2022 Dec;29(1):1409-1422. doi: 10.1080/10717544.2022.2069880.
6
Research Progress of Preparation Technology of Ion-Exchange Resin Complexes.离子交换树脂配合物的制备技术研究进展。
AAPS PharmSciTech. 2022 Apr 5;23(4):105. doi: 10.1208/s12249-022-02260-6.
7
Mental Health Nurses' Tacit Knowledge of Strategies for Improving Medication Adherence for Schizophrenia: A Qualitative Study.精神科护士对改善精神分裂症患者服药依从性策略的隐性知识:一项定性研究。
Healthcare (Basel). 2022 Mar 7;10(3):492. doi: 10.3390/healthcare10030492.
8
Study on the Complexation and Release Mechanism of Methylphenidate Hydrochloride Ion Exchange Resin Complex.盐酸哌甲酯离子交换树脂复合物的络合及释放机制研究
Polymers (Basel). 2021 Dec 15;13(24):4394. doi: 10.3390/polym13244394.
9
Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia.精神分裂症退伍军人从每月一次帕利哌酮棕榈酸酯治疗转换为每三个月一次治疗
Neuropsychiatr Dis Treat. 2021 Oct 19;17:3159-3170. doi: 10.2147/NDT.S313067. eCollection 2021.
10
Comparison of Three Different Aqueous Microenvironments for Enhancing Oral Bioavailability of Sildenafil: Solid Self-Nanoemulsifying Drug Delivery System, Amorphous Microspheres and Crystalline Microspheres.三种不同水介质环境对提高西地那非口服生物利用度的比较:固体自微乳药物传递系统、无定形微球和结晶微球。
Int J Nanomedicine. 2021 Aug 24;16:5797-5810. doi: 10.2147/IJN.S324206. eCollection 2021.